Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Identify smart fund options for retirement diversification, focusing on balance, risk management, and practical allocation ideas for real-world use.
24,189 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
New federal disclosures reveal a striking jump in NFT-related income for a high-profile figure, underscoring the grow...
Nvidia just stunned investors with a blowout earnings report. As the stock vaults higher, you may wonder: should nvid...
First Advantage stock is climbing today as investors react to better-than-expected results and a growing AI-focused d...
When a company's top executive sells a large chunk of stock, investors take note. This article dives into Privia Heal...
MP Materials faced a notable price drop in June, but the reasons run deeper than a single policy move. This article b...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...
Insider moves can spark questions about a stock's future. This guide breaks down what insw sold discretionary shares ...
Qualcomm unveils a bold AI-backed diversification plan led by CIO Attila Tinic, targeting data centers, automotive an...
Amprius (AMPX) 2025 earnings offer insight into a niche but promising battery player. This article breaks down what t...
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...